| A comprehensive review of COVID-19 characteristics H Esakandari, M Nabi-Afjadi, J Fakkari-Afjadi, N Farahmandian, ... Biological procedures online 22, 1-10, 2020 | 719 | 2020 |
| Anti-cancer peptide-based therapeutic strategies in solid tumors M Karami Fath, K Babakhaniyan, M Zokaei, A Yaghoubian, S Akbari, ... Cellular & Molecular Biology Letters 27 (1), 33, 2022 | 76 | 2022 |
| The role of epigenetic modifications in drug resistance and treatment of breast cancer M Karami Fath, A Azargoonjahromi, A Kiani, F Jalalifar, P Osati, ... Cellular & Molecular Biology Letters 27 (1), 52, 2022 | 66 | 2022 |
| Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine M Esmaily, A Masjedi, S Hallaj, MN Afjadi, F Malakotikhah, S Ghani, ... Journal of Controlled Release 326, 63-74, 2020 | 64 | 2020 |
| Lectins and lectibodies: potential promising antiviral agents M Nabi-Afjadi, M Heydari, H Zalpoor, I Arman, A Sadoughi, P Sahami, ... Cellular & Molecular Biology Letters 27 (1), 37, 2022 | 40 | 2022 |
| Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells V Karpisheh, JF Afjadi, MN Afjadi, MS Haeri, TSA Sough, SH Asl, ... International Journal of Biological Macromolecules 167, 1006-1019, 2021 | 38 | 2021 |
| Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy A Masjedi, A Ahmadi, S Ghani, F Malakotikhah, MN Afjadi, M Irandoust, ... Nanomedicine: Nanotechnology, Biology and Medicine 29, 102240, 2020 | 35 | 2020 |
| Quercetin as a JAK–STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases H Zalpoor, M Nabi-Afjadi, R Forghaniesfidvajani, C Tavakol, ... Cellular & molecular biology letters 27 (1), 60, 2022 | 33 | 2022 |
| Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression N Joshi, F Hajizadeh, EA Dezfouli, AO Zekiy, MN Afjadi, SM Mousavi, ... Life sciences 275, 119369, 2021 | 33 | 2021 |
| Quercetin potential effects against SARS‐CoV‐2 infection and COVID‐19‐associated cancer progression by inhibiting mTOR and hypoxia‐inducible factor‐1α (HIF‐1α) H Zalpoor, M Bakhtiyari, M Liaghat, M Nabi‐Afjadi, ... Phytotherapy Research 36 (7), 2679, 2022 | 32 | 2022 |
| Concomitant blockade of A2AR and CTLA‐4 by siRNA‐loaded polyethylene glycol‐chitosan‐alginate nanoparticles synergistically enhances antitumor T‐cell responses M Ghasemi‐Chaleshtari, SH Kiaie, M Irandoust, H Karami, M Nabi Afjadi, ... Journal of Cellular Physiology 235 (12), 10068-10080, 2020 | 31 | 2020 |
| Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways H Zalpoor, M Bakhtiyari, H Shapourian, P Rostampour, C Tavakol, ... Inflammopharmacology 30 (5), 1533-1539, 2022 | 30 | 2022 |
| The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors H Zalpoor, F Aziziyan, M Liaghat, M Bakhtiyari, A Akbari, M Nabi-Afjadi, ... Cell Communication and Signaling 20 (1), 186, 2022 | 29 | 2022 |
| Current understanding of epigenetics role in melanoma treatment and resistance M Karami Fath, A Azargoonjahromi, A Soofi, F Almasi, S Hosseinzadeh, ... Cancer cell international 22 (1), 313, 2022 | 29 | 2022 |
| The effect of vitamin D, magnesium and zinc supplements on interferon signaling pathways and their relationship to control SARS-CoV-2 infection M Nabi-Afjadi, H Karami, K Goudarzi, I Alipourfard, E Bahreini Clinical and Molecular Allergy 19, 1-10, 2021 | 28 | 2021 |
| Different T cell related immunological profiles in COVID-19 patients compared to healthy controls AMS Khesht, V Karpisheh, BQ Saeed, AO Zekiy, LM Yapanto, MN Afjadi, ... International Immunopharmacology 97, 107828, 2021 | 28 | 2021 |
| Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid M Karami Fath, J Azami, N Jaafari, M Akbari Oryani, N Jafari, ... Cellular & Molecular Biology Letters 27 (1), 74, 2022 | 26 | 2022 |
| Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases H Zalpoor, A Akbari, M Nabi-Afjadi Human Cell 35 (3), 952-954, 2022 | 26 | 2022 |
| Investigation of insulin-like growth factors/insulin-like growth factor binding proteins regulation in metabolic syndrome patients S Pouriamehr, H Barmaki, M Rastegary, F Lotfi, M Nabi Afjadi BMC research notes 12, 1-5, 2019 | 23 | 2019 |
| Hypoxia‐inducible factor 1 alpha (HIF‐1α) stimulated and P2X7 receptor activated by COVID-19, as a potential therapeutic target and risk factor for epilepsy H Zalpoor, A Akbari, M Nabi-Afjadi, R Forghaniesfidvajani, C Tavakol, ... Human Cell 35 (5), 1338-1345, 2022 | 20 | 2022 |
zahra payandehKarolinska Institutet在 ki.se 的电子邮件经过验证
